Richter syndrome: molecular insights and clinical perspectives.
about
Chronic lymphocytic leukemia: a clinical review including Korean cohortsTransformation of Canine Lymphoma/Leukemia to More Aggressive Diseases: Anecdotes or Reality?Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolutionAnalysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin LymphomaChronic lymphocytic leukemia transformation into high-grade lymphoma: a description of Richter's syndrome in eight dogs.Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia.VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell typeRichter transformation with c-MYC overexpression: report of three cases.Genetic lesions in diffuse large B-cell lymphomasMDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome.Molecular pathogenesis of chronic lymphocytic leukemia.Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndromeDiffuse large B-cell lymphoma arising in a composite lymphoma with biclonality by flow cytometry and one monoclonal band by PCRChylothorax Associated with Chronic Lymphocytic Leukemia.The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal.Ibrutinib, obinutuzumab, idelalisib, and beyond: review of novel and evolving therapies for chronic lymphocytic leukemia.An update for Richter syndrome - new directions and developments.Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.The genome of chemorefractory chronic lymphocytic leukemia reveals frequent mutations of NOTCH1 and SF3B1.Cytogenetic and flow cytometry evaluation of Richter syndrome reveals MYC, CDKN2A, IGH alterations with loss of CD52, CD62L and increase of CD71 antigen expression as the most frequent recurrent abnormalities.Biological and clinical significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.Richter syndrome with follicular colonization of chronic lymphocytic leukemia/small lymphocytic lymphoma cells mimicking follicular lymphoma.Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature.Epstein-Barr virus-positive diffuse large B cell lymphoma arising from a chronic lymphocytic leukemia: Overlapping features with classical Hodgkin lymphoma.Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice.BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma.Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.Richter's transformation presenting as splenic rupture after 6 years of complete remission of chronic lymphocytic leukaemia.Association of peripheral CD4+ CXCR5+ T cells with chronic lymphocytic leukemia.Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.An 18F-FDG-PET maximum standardized uptake value > 10 represents a novel valid marker for discerning Richter's Syndrome.Richter syndrome and fludarabine: a controversial relationship.NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients.
P2860
Q26752467-068DB4E6-FC62-4953-B225-0A792DD97058Q26776071-6AC3E2F6-0F30-4294-8D28-2043800C7C40Q26823586-5FA9F043-F469-4C82-A20F-FF049B8995FEQ27851655-5E45BF67-638B-4BCE-BC12-2FEA66E291A2Q27851685-C9531B63-6619-49CF-86E0-35A3B45CE969Q28071905-168C62A5-6A5D-4C10-B4B7-934551D4B40BQ33426684-63C0A26E-FE66-46E4-954F-783F2CD3470AQ33573355-7CDF1012-7447-4D29-922E-B2D6B2A77886Q34009015-B6889FE4-8C2A-497A-AFDF-4747AC59C14CQ34534640-090C9E63-C7D8-47E0-B082-E39B50A53C22Q35919565-60C0AB50-CDC2-4993-853B-80D084517531Q35974341-B0C91687-8D60-4F9D-89FB-426566321E04Q36135857-B6333E82-430B-411D-B5F4-6F19C8482488Q36290321-2A9EFF97-5704-4985-A8CE-85EE2575CA80Q36826893-56828574-0C12-4E9E-BDC6-8BFB8160B877Q37246532-55A25A47-95E1-43E1-8BB8-C5FF20659EEAQ37452357-9E8DC858-4A44-4B89-A275-CA253C191BE2Q37616842-9C2FC022-A204-4B11-98CB-510269B01EE5Q38088852-3C47A91B-9234-4BE6-B04B-F624D445240DQ38263806-60468315-25F7-4E67-B744-E9515F92A442Q38691261-64D3B37F-3C19-4A41-9124-09DBAD2775DEQ38896306-FCD7C642-55B6-441B-A5F3-A7BFD9F0FDEBQ39230986-A98CD183-6F23-4210-8F7A-AA5E4AF72B8DQ40291554-996E07EA-01F1-4A38-9845-A848A3073DA7Q40817325-570B3173-17E0-4AFC-949B-781F79CD0CA7Q41686070-7104E2C4-261D-468A-8C8B-BA5827768F5DQ42337469-ADA9875B-80A1-4460-B294-FE52294F4A1EQ43959705-E592FB9D-E83A-436F-B7F5-D1DF8A6D3282Q44741136-CD848048-B2F8-46F4-9FFF-067479B544B2Q45336279-6D366B27-C8F5-4F95-AAC2-B87303C27838Q45806334-518EEB11-82D2-4803-A299-50DADF7406D2Q46113631-2A428F31-354B-485D-B65A-CB6F02E1FE41Q47739621-70D43467-8F82-40D5-9E6B-0C76A0D627EBQ48204606-ED683F48-8FE3-49DC-9F73-7ADD47453D2DQ50871917-EDC9F7E0-12E1-45D6-B40A-1EA5950A5D40Q52614373-4BA8C6F4-764A-47EA-9321-B3857962C823Q52990703-217053C7-260D-4110-A382-6003A4B99B83Q53151016-5F7D5B80-DFB1-47DF-9EF8-AFC1011FC3BFQ53259951-ECF7C7D0-961B-4F58-AA17-1642F2362756Q55018202-12F64275-38DA-4E6B-9BE8-C27EE88F31DF
P2860
Richter syndrome: molecular insights and clinical perspectives.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Richter syndrome: molecular insights and clinical perspectives.
@ast
Richter syndrome: molecular insights and clinical perspectives.
@en
Richter syndrome: molecular insights and clinical perspectives.
@nl
type
label
Richter syndrome: molecular insights and clinical perspectives.
@ast
Richter syndrome: molecular insights and clinical perspectives.
@en
Richter syndrome: molecular insights and clinical perspectives.
@nl
prefLabel
Richter syndrome: molecular insights and clinical perspectives.
@ast
Richter syndrome: molecular insights and clinical perspectives.
@en
Richter syndrome: molecular insights and clinical perspectives.
@nl
P2860
P356
P1476
Richter syndrome: molecular insights and clinical perspectives.
@en
P2093
Davide Rossi
P2860
P356
10.1002/HON.880
P577
2009-03-01T00:00:00Z